BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 7931663)

  • 41. Clinical practice in radioembolization of hepatic malignancies: a survey among interventional centers in Europe.
    Powerski MJ; Scheurig-Münkler C; Banzer J; Schnapauff D; Hamm B; Gebauer B
    Eur J Radiol; 2012 Jul; 81(7):e804-11. PubMed ID: 22546235
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Intrahepatic (90)Y-microspheres for hepatocellular carcinoma.
    Ho S; Lau JW; Leung TW
    J Nucl Med; 2001 Oct; 42(10):1587-9. PubMed ID: 11585877
    [No Abstract]   [Full Text] [Related]  

  • 43. Use of Yttrium-90 TheraSphere for the treatment of unresectable hepatocellular carcinoma.
    Liu MD; Uaje MB; Al-Ghazi MS; Fields D; Herman J; Kuo JV; Milne N; Nguyen TH; Ramsinghani NS; Tokita KM; Tsai FY; Vajgrt DJ; Imagawa DK
    Am Surg; 2004 Nov; 70(11):947-53. PubMed ID: 15586503
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Technical aspects of radioembolization with 90Y microspheres.
    Salem R; Lewandowski RJ; Sato KT; Atassi B; Ryu RK; Ibrahim S; Nemcek AA; Omary RA; Madoff DC; Murthy R
    Tech Vasc Interv Radiol; 2007 Mar; 10(1):12-29. PubMed ID: 17980315
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Treatment parameters and outcome in 680 treatments of internal radiation with resin 90Y-microspheres for unresectable hepatic tumors.
    Kennedy AS; McNeillie P; Dezarn WA; Nutting C; Sangro B; Wertman D; Garafalo M; Liu D; Coldwell D; Savin M; Jakobs T; Rose S; Warner R; Carter D; Sapareto S; Nag S; Gulec S; Calkins A; Gates VL; Salem R
    Int J Radiat Oncol Biol Phys; 2009 Aug; 74(5):1494-500. PubMed ID: 19157721
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Ultrasound-guided internal radiotherapy using yttrium-90-glass microspheres for liver malignancies.
    Tian JH; Xu BX; Zhang JM; Dong BW; Liang P; Wang XD
    J Nucl Med; 1996 Jun; 37(6):958-63. PubMed ID: 8683320
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Yttrium-90 radioembolization in the management of liver malignancies.
    Riaz A; Kulik LM; Mulcahy MF; Lewandowski RJ; Salem R
    Semin Oncol; 2010 Apr; 37(2):94-101. PubMed ID: 20494701
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Radiologic findings following Y90 radioembolization for primary liver malignancies.
    Ibrahim SM; Nikolaidis P; Miller FH; Lewandowski RJ; Ryu RK; Sato KT; Senthilnathan S; Riaz A; Kulik L; Mulcahy MF; Omary RA; Salem R
    Abdom Imaging; 2009; 34(5):566-81. PubMed ID: 18777189
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Hepatic malignancies: improved treatment with intraarterial Y-90.
    Herba MJ; Illescas FF; Thirlwell MP; Boos GJ; Rosenthall L; Atri M; Bret PM
    Radiology; 1988 Nov; 169(2):311-4. PubMed ID: 3174978
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Hepatobiliary effects of 90yttrium microsphere therapy for unresectable hepatocellular carcinoma.
    Nalesnik MA; Federle M; Buck D; Fontes P; Carr BI
    Hum Pathol; 2009 Jan; 40(1):125-34. PubMed ID: 18799190
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Evaluation of hepatic angiography procedures and bremsstrahlung imaging in selective internal radiation therapy: a two-year single-center experience.
    Sebastian AJ; Szyszko T; Al-Nahhas A; Nijran K; Tait NP
    Cardiovasc Intervent Radiol; 2008; 31(3):643-9. PubMed ID: 18273668
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [90Y glass microspheres intraradiopraxis of advanced hepatic carcinoma].
    Huang C; Huang J; Yang W; Chen Y; Shen J; Chen W; Yang F; Chen H
    Zhonghua Wai Ke Za Zhi; 1998 Apr; 36(4):206-8. PubMed ID: 11825367
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Three-dimensional tumor dosimetry for hepatic yttrium-90-microsphere therapy.
    Roberson PL; Ten Haken RK; McShan DL; McKeever PE; Ensminger WD
    J Nucl Med; 1992 May; 33(5):735-8. PubMed ID: 1569483
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The effect of catheter-directed CT angiography on yttrium-90 radioembolization treatment of hepatocellular carcinoma.
    Rhee TK; Omary RA; Gates V; Mounajjed T; Larson AC; Barakat O; Sato KT; Mulcahy M; Gordon S; Lewandowski RJ; Salem R
    J Vasc Interv Radiol; 2005 Aug; 16(8):1085-91. PubMed ID: 16105920
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Quality assurance issues for therapeutic application of radioactive microspheres.
    Dezarn WA
    Int J Radiat Oncol Biol Phys; 2008; 71(1 Suppl):S147-51. PubMed ID: 18406915
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Intrahepatic Activity Distribution in Radioembolization with Yttrium-90-Labeled Resin Microspheres Using the Body Surface Area Method--A Less than Perfect Model.
    Grosser OS; Ulrich G; Furth C; Pech M; Ricke J; Amthauer H; Ruf J
    J Vasc Interv Radiol; 2015 Nov; 26(11):1615-21. PubMed ID: 26321017
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Malignant insulinomas with hepatic metastases successfully treated with selective internal radiation therapy.
    Ho KW; Wong CC; Balalla B; Diamond T
    Clin Endocrinol (Oxf); 2006 Sep; 65(3):410-1. PubMed ID: 16918967
    [No Abstract]   [Full Text] [Related]  

  • 58. Internal dosimetry for radioembolization therapy with Yttrium-90 microspheres.
    Fallahpoor M; Abbasi M; Parach AA; Kalantari F
    J Appl Clin Med Phys; 2017 Mar; 18(2):176-180. PubMed ID: 28300366
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [In situ therapy of deep-seated canver by radioactive microspheres].
    Kawashita M
    Nihon Hoshasen Gijutsu Gakkai Zasshi; 2002 May; 58(5):585-91. PubMed ID: 12520226
    [No Abstract]   [Full Text] [Related]  

  • 60. Yttrium-90 microspheres for the treatment of hepatocellular carcinoma: a review.
    Salem R; Hunter RD
    Int J Radiat Oncol Biol Phys; 2006; 66(2 Suppl):S83-8. PubMed ID: 16979447
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.